Emerging science reveals how repetitive head impacts in sports leave lasting molecular signatures detectable in blood biomarkers, offering early warning for neurological risks.
Explore how neurologic concussion biomarkers are transforming diagnosis through point-of-care testing, enabling faster and more accurate detection of traumatic brain injuries.
Discover how blood biomarkers like GFAP, UCH-L1, S100B, and hsCRP are revolutionizing traumatic brain injury diagnosis and prognosis, especially in children.
Discover how UCHL1, SNRNP200, and PAK4 proteins create a molecular fingerprint that predicts kidney cancer aggressiveness and patient outcomes.
Discover how GFAP and UCH-L1 biomarkers are transforming traumatic brain injury diagnosis through a simple blood test, reducing unnecessary CT scans and improving patient care.
Discover how biomarkers GFAP and UCH-L1 are transforming traumatic brain injury diagnosis through simple blood tests, reducing unnecessary CT scans and improving patient outcomes.
Exploring the diagnostic revolution for Frontotemporal Lobar Degeneration and Dementia with Lewy Bodies through advanced biomarkers and imaging technologies.
Discover how serum biomarkers like NfL and tau are revolutionizing delirium diagnosis and research through cutting-edge scientific studies.
Emerging research into protein biomarkers in blood offers new ways to predict recovery after spinal cord injuries, with UCH-L1 showing particular promise.
Discover how UBE2N and PSME3 proteins serve as potential biomarkers for early colorectal cancer detection through advanced proteomic analysis.